耳鼻喉科設備市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機遇和預測，按類型、最終用戶、地區和競爭細分

由於人們對聽力損失和言語相關疾病的認知不斷提高，預計全球耳鼻喉設備市場在預測期內將以驚人的速度成長。此外，技術進步在新型和先進耳鼻喉設備的開發中發揮了關鍵作用。這些設備提供更準確的診斷、微創治療並改善患者的治療效果。例如，數位成像技術使得捕捉耳、鼻、喉的高解析度圖像成為可能，使醫生更容易診斷和治療耳鼻喉科疾病。同樣，使用專用器械的微創外科手術減少了對傳統開放手術的需求，從而縮短了恢復時間並減少了併發症。反過來，預計這將為未來幾年全球耳鼻喉設備市場的成長開闢新的前景。

耳鼻喉科疾病的患病率不斷增加

近年來，聽力損失、耳鳴、慢性鼻竇炎和聲音障礙等耳鼻喉科疾病的患病率顯著增加。根據世界衛生組織(WHO) 的數據，全球約有4.66 億人患有殘疾性聽力損失，預計到2050 年這一數位將增加到9 億。耳鼻喉疾病患病率的上升導致對耳鼻喉設備的需求增加有助於診斷、治療和管理這些疾病，從而推動全球耳鼻喉科設備市場的成長。根據國家耳聾和其他溝通障礙研究所的數據，大約 15% 的 18 歲以上美國成年人有聽力問題。此外，在美國65歲至74歲之間，三分之一的人有聽力損失，75歲以上的人中有一半以上有聽力困難。根據美國疾病控制與預防中心的數據，在美國，聽力損失的患病率是糖尿病或癌症的兩倍。反過來，預計這將增加未來幾年對耳鼻喉科設備的需求，從而支持全球耳鼻喉科設備市場到 2028 年的成長。

新興耳鼻喉科設備技術

細胞在耳鼻喉科設備中的使用有可能徹底改變整個全球耳鼻喉科設備市場。與傳統傷口護理方法相比，這些療法具有多種優勢，並且有可能顯著改善患者的治療效果。隨著再生醫學領域的不斷發展，細胞在耳鼻喉科設備中的使用可能會變得越來越普遍，為患有慢性傷口的患者帶來新的希望，並為未來幾年全球耳鼻喉科設備市場的成長創造新的前景。

人口老齡化

人口老齡化是推動全球耳鼻喉科設備市場需求的另一個因素。隨著人們年齡的成長，他們更容易患耳鼻喉科疾病，如聽力損失、耳鳴和慢性鼻竇炎。據聯合國稱，到 2050 年，全球 60 歲及以上人口預計將從 2017 年的 9.62 億增加到 21 億。老齡化人口的增加可能會導致對耳鼻喉科設備的更高需求，從而支持全球耳鼻喉科設備市場的成長。

提高意識

人們越來越認知到耳鼻喉科疾病及其對生活品質的影響。這導致更多的人因這些病症尋求醫療護理以及對耳鼻喉設備的需求增加，從而推動全球耳鼻喉設備市場的成長。例如，旨在提高人們對聽力損失及其對社會和經濟參與影響的認知的活動有助於減少與助聽器相關的恥辱並提高其使用率。

技術進步

3D列印、數位成像和遠程醫療等進步正在徹底改變耳鼻喉科領域，並為全球耳鼻喉科設備市場的成長創造新的前景。 3D 列印徹底改變了耳鼻喉科設備的製造方式，能夠創建適合每位患者獨特解剖結構的客製化設備。例如，3D 列印已被用來為先天性耳朵畸形或耳朵截肢的患者製作客製化的耳朵假體。該技術還用於創建解剖模型，用於術前規劃和手術模擬，提高手術精度並減少併發症。數位成像技術改變了耳鼻喉疾病的診斷和治療，使耳鼻喉的可視化更加準確和詳細。 CT 掃描和 MRI 掃描已成為診斷複雜耳鼻喉疾病的標準，而數位耳鏡和鼻咽鏡則提高了診斷的準確性並減少了侵入性手術的需要。遠程醫療的興起使耳鼻喉科護理變得更加容易，特別是對於偏遠或服務欠缺地區的患者而言。遠程醫療技術可以讓醫生遠程會診、診斷和治療，減少出差，加快診斷和治療速度。助聽器和其他耳鼻喉設備的遠程監控也已成為可能，允許醫生調整設置並提供遠程支持。這些進步預計將在未來幾年支持全球耳鼻喉科設備市場的成長。

最近的發展

• OtoSet - 創新的耳朵清潔設備 OtoSet 是 SafKan Health 於 2021 年推出的一款新型耳朵清潔設備。它旨在安全有效地清除耳垢，可供患者在家中使用。該設備易於使用，並配有拋棄式尖端，使其成為比傳統棉籤更衛生的選擇。 OtoSet 因其有效性和易用性而在市場上廣受歡迎。
• 2021 年 2 月，GN Store Nord A/S 推出了 ReSound Key，這是一個助聽器系列，為其全球現有的助聽設備技術提供了附加值。
• 2020 年 10 月，斯達克聽力技術公司與以色列公司 OrCam Technologies 建立合作夥伴關係，為聽力和視力障礙人士提供輔助技術。此次合作將增強 OrCam Technologies 應用機器學習和電腦視覺等先進技術的能力，這些技術是他們之前與 Starkey 的 Livio Edge AI 助聽器合作開發的，通過音頻傳輸視覺世界。
• 2020 年 9 月，GN Store Nord A/S 推出了 ReSound ONE 助聽設備。這種助聽設備在耳道內放置了一個額外的麥克風，麥克風和接收器採用入耳式設計，利用個人耳朵的獨特形狀來收集聲音。
• 2020 年 7 月，Cochlear Limited 的 Cochlear Nucleus Kanso 2 聲音處理器、適用於 Nucleus 22 植入者的 Nucleus 7 聲音處理器以及 Custom Sound Pro 驗配軟體獲得美國 FDA 批准。
• 2020 年 4 月，Sonova Holdings AG 採用遠程醫療技術，並開始提供由峰力 eSolutions 套件組成的遠程聽力學服務。這些解決方案將包括線上聽力測試和助聽設備的即時遠程驗配及其編程和微調

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

• 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

• 市場定義
• 市場範圍
  • 涵蓋的市場
  • 考慮學習的年份
  • 主要市場細分

第 2 章：研究方法

• 研究目的
• 基線方法
• 主要行業合作夥伴
• 主要協會和二手資料來源
• 預測方法
• 數據三角測量和驗證
• 假設和限制

第 3 章：執行摘要

• 市場概況
• 主要市場細分概述
• 主要市場參與者概述
• 重點地區/國家概況
• 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球耳鼻喉科設備市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按類型（診斷設備、手術設備、助聽器、聽力植入物、鼻夾板、其他）
  • 按最終用戶（醫院、耳鼻喉科診所、門診護理機構、其他）
  • 按地區
  • 按公司分類 (2022)
• 產品圖
  • 按類型
  • 按最終用戶
  • 按地區

第 6 章：北美耳鼻喉科設備市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按類型（診斷設備、手術設備、助聽器、聽力植入物、鼻夾板、其他）
  • 按最終用戶（醫院、耳鼻喉科診所、門診護理機構、其他）
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第 7 章：歐洲耳鼻喉科設備市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按類型（診斷設備、手術設備、助聽器、聽力植入物、鼻夾板、其他）
  • 按最終用戶（醫院、耳鼻喉科診所、門診護理機構、其他）
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第 8 章：亞太地區耳鼻喉科設備市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按類型（診斷設備、手術設備、助聽器、聽力植入物、鼻夾板、其他）
  • 按最終用戶（醫院、耳鼻喉科診所、門診護理機構、其他）
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳大利亞

第 9 章：南美耳鼻喉科設備市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按類型（診斷設備、手術設備、助聽器、聽力植入物、鼻夾板、其他）
  • 按最終用戶（醫院、耳鼻喉科診所、門診護理機構、其他）
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲耳鼻喉科設備市場展望

• 市場規模及預測
  • 按價值
• 市場佔有率及預測
  • 按類型（診斷設備、手術設備、助聽器、聽力植入物、鼻夾板、其他）
  • 按最終用戶（醫院、耳鼻喉科診所、門診護理機構、其他）
  • 按國家/地區
• MEA：國家分析
  • 南非耳鼻喉科設備
  • 沙烏地阿拉伯耳鼻喉科設備
  • 阿拉伯聯合大公國耳鼻喉科設備

第 11 章：市場動態

• 司機
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球耳鼻喉科設備市場：SWOT 分析

第 14 章：波特的五力分析

• 行業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第15章：競爭格局

• 商業概覽
• 產品供應
• 最近的發展
• 主要人員
  • Medtronic Plc
  • Demant A/S
  • Sonova Holdings AG
  • Ambu A/S
  • GN Store Nord A/S
  • Olympus Corporation
  • Starkey Laboratories, Inc.
  • Rion Co., Ltd.
  • Karl Storz Gmbh & Co., KG
  • Stryker Corporation
  • WS Audiology A/S
  • Hill-Rom Holdings Inc.
  • Johnson & Johnson (Acclarent, Inc.)
  • Cochlear Limited
  • Smith & Nephew Plc

第 16 章：戰略建議

Global ENT Devices Market is expected to grow at an impressive rate during the forecast period on account of the rising awareness about hearing loss and speech-related conditions among the population. Additionally, technological advancements have played a key role in the development of new and advanced ENT devices. These devices offer more accurate diagnosis, minimally invasive treatment, and improved patient outcomes. For instance, digital imaging technology has made it possible to capture high-resolution images of the ear, nose, and throat, making it easier for doctors to diagnose and treat ENT disorders. Similarly, minimally invasive surgical procedures using specialized instruments have reduced the need for traditional open surgery, leading to faster recovery times and reduced complications. This, in turn, is expected to open new prospects for the growth of global ENT devices market in the coming years.

ENT devices play a crucial role in the diagnosis and treatment of a range of ear, nose, and throat conditions. They are essential tools for healthcare providers to accurately diagnose and effectively treat their patients. With advancements in technology, ENT devices are becoming more advanced, user-friendly, and effective at improving the quality of life for individuals with hearing and speech-related conditions.

Increasing Prevalence of ENT Disorders

There has been a significant increase in the prevalence of ENT disorders such as hearing loss, tinnitus, chronic sinusitis, and voice disorders in recent years. According to the World Health Organization (WHO), around 466 million people worldwide have disabling hearing loss, and this number is expected to increase to 900 million by 2050. This rise in the prevalence of ENT disorders has led to an increased demand for ENT devices that can help in the diagnosis, treatment, and management of these conditions, thereby driving the growth of global ENT devices market. According to National Institute on Deafness and Other Communication Disorders, around 15% of American adults who are above 18 years of age have reported trouble hearing. Also, one out of three people in the United States between the ages 65 and 74 has hearing loss, and more than half of the people older than 75 years of age have difficulty in hearing. According to the US Centers for Disease Control and Prevention, the prevalence of hearing loss is twice as common as diabetes or cancer in the United States. This, in turn, is expected to increase the demand for ENT devices in the coming years, thereby supporting the growth of global ENT devices market through 2028.

Emerging ENT Devices Techniques

The use of cells in ENT Devices has the potential to revolutionize the overall global ENT Devices market. These therapies offer several advantages over traditional wound care methods and have the potential to significantly improve patient outcomes. As the field of regenerative medicine continues to evolve, the use of cells in ENT Devices is likely to become increasingly common, offering new hope for patients suffering from chronic wounds and creating new prospects for the growth of global ENT Devices market in the coming years.

Aging Population

The aging population is another factor that is driving the demand for global ENT devices market. As people age, they become more prone to ENT disorders such as hearing loss, tinnitus, and chronic sinusitis. According to the United Nations, the global population aged 60 and above is expected to reach 2.1 billion by 2050, up from 962 million in 2017. This increase in the aging population is likely to lead to a higher demand for ENT devices, thereby supporting the growth of global ENT devices market.

Increasing Awareness

There has been an increasing awareness of ENT disorders and their impact on quality of life. This has led to more people seeking medical attention for these conditions and an increased demand for ENT devices, thereby driving the growth of global ENT devices market. For instance, campaigns aimed at raising awareness of hearing loss and its impact on social and economic participation have helped to reduce the stigma associated with hearing aids and increase their uptake.

Technological Advancements

Advancements like 3D printing, digital imaging, and telemedicine, among others, are all revolutionizing the field of ENT and creating new prospects for the growth of global ENT devices market. 3D printing has revolutionized the manufacturing of ENT devices, enabling the creation of customized devices that fit the unique anatomy of each patient. For instance, 3D printing has been used to create custom-made ear prostheses for patients with congenital ear deformities or ear amputations. This technology has also been used to create anatomical models for preoperative planning and surgical simulation, improving surgical precision and reducing complications. Digital imaging technology has transformed the diagnosis and treatment of ENT disorders, allowing for more accurate and detailed visualization of the ear, nose, and throat. CT scans and MRI scans have become standard in the diagnosis of complex ENT conditions, while digital otoscopes and nasopharyngoscopes have improved the accuracy of diagnosis and reduced the need for invasive procedures. The rise of telemedicine has made ENT care more accessible, particularly for patients in remote or underserved areas. Telemedicine technology allows doctors to consult with patients and provide diagnosis and treatment remotely, reducing the need for travel and allowing for faster diagnosis and treatment. Remote monitoring of hearing aids and other ENT devices has also become possible, allowing doctors to adjust settings and provide support from a distance. Such advancements are expected to support the growth of global ENT devices market in the coming years.

Market Segmentation

Global ENT Devices Market can be segmented by type, end-user, and by region. Based on type, global ENT Devices market can be categorized into diagnostic devices, surgical devices, hearing aid devices, hearing implants, nasal splints, and others. Diagnostic devices can be further categorized into rigid endoscopes, flexible endoscopes, robot-assisted endoscopes, and hearing screening devices. The surgical devices can be further segmented into radiofrequency handpieces, otological drill burrs, ENT hand instruments, and others. The hearing-aid-devices can be grouped into behind-the-ear-aids, in-the-ear-aids, in-the-canal-aids, and on-the-ear-aids. The hearing implants can be further sub-segmented into cochlear implants, bone-anchored hearing systems (BAHS), auditory brainstem implants, and middle ear implants. Nasal splints can be split into internal nasal splints and external nasal splints. Based on end-user, the global ENT devices can be categorized into hospitals, ENT clinics, ambulatory care settings, and others. Regionally, the global ENT devices market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Medtronic Plc, Demant A/S, Sonova Holdings AG, Ambu A/S, GN Store Nord A/S, Olympus Corporation, Starkey Laboratories, Inc., Rion Co., Ltd., Karl Storz Gmbh & Co., KG, Stryker Corporation, WS Audiology A/S, Hill-Rom Holdings Inc., Johnson & Johnson (Acclarent, Inc.), Cochlear Limited, Smith & Nephew Plc., among others are some of the leading players operating in the global ENT Devices market.

Recent Developments

• OtoSet - An Innovative Ear Cleaning Device OtoSet is a new ear cleaning device that was launched in 2021 by SafKan Health. It is designed to remove earwax safely and efficiently and can be used by patients at home. The device is easy to use and comes with disposable tips, making it a more hygienic option than traditional cotton swabs. OtoSet has already gained popularity in the market due to its effectiveness and ease of use.
• In February 2021, GN Store Nord A/S launched ReSound Key, which is a hearing-aid lineup that provides a value addition to its existing hearing-aid devices technology globally.
• In October 2020, Starkey Hearing Technologies entered into a partnership with an Israel-based company, OrCam Technologies, in order to provide assistive technologies to hearing and visually impaired people. This partnership will enhance OrCam Technologies' abilities in applying machine learning and advanced technologies such as computer vision which they have earlier developed to transmit the visual world through audio in collaboration with Starkey's Livio Edge AI hearing aids.
• In September 2020, GN Store Nord A/S launched ReSound ONE Hearing-Aid Device. This hearing-aid device puts an additional microphone inside the ear canal with a microphone and receiver-in-ear design which uses the unique shape of an individual's ear to collect the sound.
• In July 2020, Cochlear Limited received the US FDA approval for its Cochlear Nucleus Kanso 2 Sound Processor, Nucleus 7 Sound Processor for Nucleus 22 Implant recipients, and Custom Sound Pro fitting software.
• In April 2020, Sonova Holdings AG adopted telemedicine technology and started providing tele-audiology services consisting of a package of its Phonak eSolutions. These solutions will be comprised of online hearing test and real-time remote fitting of hearing-aid devices along with their programming and fine-tuning

Report Scope:

In this report, Global ENT Devices Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

ENT Devices Market, By Type:

• Diagnostic Devices
• Rigid Endoscopes
• Flexible Endoscopes
• Robot Assisted Endoscopes
• Hearing Screening Devices
• Surgical Devices
• Radiofrequency Handpieces
• Otological Drill Burrs
• ENT Hand Instruments
• Others
• Hearing Aid Devices
• Behind-the-ear-aids
• In-the-ear-aids
• In-the-canal-aids
• On-the-ear-aids
• Hearing Implants
• Cochlear Implants
• Bone-Anchored Hearing Systems (BAHS)
• Auditory Brainstem Implants
• Middle Ear Implants
• Nasal Splints
• Internal Nasal Splints
• External Nasal Splints
• Others

ENT Devices Market, By End User:

• Hospitals
• ENT Clinics
• Ambulatory Care Settings
• Others

ENT Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global ENT Devices Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global ENT Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Diagnostic Devices, Surgical Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints, Others)
    • 5.2.1.1. By Diagnostic Devices (Rigid Endoscopes, Flexible Endoscopes, Robot Assisted Endoscopes, Hearing Screening Devices)
    • 5.2.1.2. By Surgical Devices (Radiofrequency Handpieces, Otological Drill Burrs, ENT Hand Instruments, Others)
    • 5.2.1.3. By Hearing Aid Devices (Behind-the-ear-aids, In-the-ear-aids, In-the-canal-aids, On-the-ear-aids)
    • 5.2.1.4. By Hearing Implants (Cochlear Implants, Bone-Anchored Hearing Systems (BAHS), Auditory Brainstem Implants, Middle Ear Implants)
    • 5.2.1.5. By Nasal Splints (Internal Nasal Splints v/s External Nasal Splints)
  • 5.2.2. By End User (Hospitals, ENT Clinics, Ambulatory Care Settings, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Product Map
  • 5.3.1. By Type
  • 5.3.2. By End User
  • 5.3.3. By Region

6. North America ENT Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Diagnostic Devices, Surgical Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints, Others)
    • 6.2.1.1. By Diagnostic Devices (Rigid Endoscopes, Flexible Endoscopes, Robot Assisted Endoscopes, Hearing Screening Devices)
    • 6.2.1.2. By Surgical Devices (Radiofrequency Handpieces, Otological Drill Burrs, ENT Hand Instruments, Others)
    • 6.2.1.3. By Hearing Aid Devices (Behind-the-ear-aids, In-the-ear-aids, In-the-canal-aids, On-the-ear-aids)
    • 6.2.1.4. By Hearing Implants (Cochlear Implants, Bone-Anchored Hearing Systems (BAHS), Auditory Brainstem Implants, Middle Ear Implants)
    • 6.2.1.5. By Nasal Splints (Internal Nasal Splints v/s External Nasal Splints)
  • 6.2.2. By End User (Hospitals, ENT Clinics, Ambulatory Care Settings, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States ENT Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada ENT Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico ENT Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe ENT Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Diagnostic Devices, Surgical Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints, Others)
    • 7.2.1.1. By Diagnostic Devices (Rigid Endoscopes, Flexible Endoscopes, Robot Assisted Endoscopes, Hearing Screening Devices)
    • 7.2.1.2. By Surgical Devices (Radiofrequency Handpieces, Otological Drill Burrs, ENT Hand Instruments, Others)
    • 7.2.1.3. By Hearing Aid Devices (Behind-the-ear-aids, In-the-ear-aids, In-the-canal-aids, On-the-ear-aids)
    • 7.2.1.4. By Hearing Implants (Cochlear Implants, Bone-Anchored Hearing Systems (BAHS), Auditory Brainstem Implants, Middle Ear Implants)
    • 7.2.1.5. By Nasal Splints (Internal Nasal Splints v/s External Nasal Splints)
  • 7.2.2. By End User (Hospitals, ENT Clinics, Ambulatory Care Settings, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France ENT Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. Germany ENT Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. United Kingdom ENT Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy ENT Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain ENT Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific ENT Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Diagnostic Devices, Surgical Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints, Others)
    • 8.2.1.1. By Diagnostic Devices (Rigid Endoscopes, Flexible Endoscopes, Robot Assisted Endoscopes, Hearing Screening Devices)
    • 8.2.1.2. By Surgical Devices (Radiofrequency Handpieces, Otological Drill Burrs, ENT Hand Instruments, Others)
    • 8.2.1.3. By Hearing Aid Devices (Behind-the-ear-aids, In-the-ear-aids, In-the-canal-aids, On-the-ear-aids)
    • 8.2.1.4. By Hearing Implants (Cochlear Implants, Bone-Anchored Hearing Systems (BAHS), Auditory Brainstem Implants, Middle Ear Implants)
    • 8.2.1.5. By Nasal Splints (Internal Nasal Splints v/s External Nasal Splints)
  • 8.2.2. By End User (Hospitals, ENT Clinics, Ambulatory Care Settings, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China ENT Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India ENT Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan ENT Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea ENT Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia ENT Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. South America ENT Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Diagnostic Devices, Surgical Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints, Others)
    • 9.2.1.1. By Diagnostic Devices (Rigid Endoscopes, Flexible Endoscopes, Robot Assisted Endoscopes, Hearing Screening Devices)
    • 9.2.1.2. By Surgical Devices (Radiofrequency Handpieces, Otological Drill Burrs, ENT Hand Instruments, Others)
    • 9.2.1.3. By Hearing Aid Devices (Behind-the-ear-aids, In-the-ear-aids, In-the-canal-aids, On-the-ear-aids)
    • 9.2.1.4. By Hearing Implants (Cochlear Implants, Bone-Anchored Hearing Systems (BAHS), Auditory Brainstem Implants, Middle Ear Implants)
    • 9.2.1.5. By Nasal Splints (Internal Nasal Splints v/s External Nasal Splints)
  • 9.2.2. By End User (Hospitals, ENT Clinics, Ambulatory Care Settings, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil ENT Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina ENT Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia ENT Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa ENT Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Diagnostic Devices, Surgical Devices, Hearing Aid Devices, Hearing Implants, Nasal Splints, Others)
    • 10.2.1.1. By Diagnostic Devices (Rigid Endoscopes, Flexible Endoscopes, Robot Assisted Endoscopes, Hearing Screening Devices)
    • 10.2.1.2. By Surgical Devices (Radiofrequency Handpieces, Otological Drill Burrs, ENT Hand Instruments, Others)
    • 10.2.1.3. By Hearing Aid Devices (Behind-the-ear-aids, In-the-ear-aids, In-the-canal-aids, On-the-ear-aids)
    • 10.2.1.4. By Hearing Implants (Cochlear Implants, Bone-Anchored Hearing Systems (BAHS), Auditory Brainstem Implants, Middle Ear Implants)
    • 10.2.1.5. By Nasal Splints (Internal Nasal Splints v/s External Nasal Splints)
  • 10.2.2. By End User (Hospitals, ENT Clinics, Ambulatory Care Settings, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa ENT Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia ENT Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE ENT Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global ENT Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
  • 15.4.1. Medtronic Plc
  • 15.4.2. Demant A/S
  • 15.4.3. Sonova Holdings AG
  • 15.4.4. Ambu A/S
  • 15.4.5. GN Store Nord A/S
  • 15.4.6. Olympus Corporation
  • 15.4.7. Starkey Laboratories, Inc.
  • 15.4.8. Rion Co., Ltd.
  • 15.4.9. Karl Storz Gmbh & Co., KG
  • 15.4.10. Stryker Corporation
  • 15.4.11. WS Audiology A/S
  • 15.4.12. Hill-Rom Holdings Inc.
  • 15.4.13. Johnson & Johnson (Acclarent, Inc.)
  • 15.4.14. Cochlear Limited
  • 15.4.15. Smith & Nephew Plc

16. Strategic Recommendations